Diabetic Peripheral Neuropathy
Conditions
Interventions
experimental group:Oral administration of Chinese Medicine+Skin needle local knock+ Cupping at the back
control group:Mecobalamin+ Lipoic acid+ Alprostadil Injection
Sponsors
Sichuan Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. It conforms to the diagnostic criteria of diabetes mellitus and DSPN; 2. Clinical symptoms (pain, numbness, abnormal sensation, etc.); 3. No therapeutic Chinese and Western medicines have been used in the past two weeks; 4. Aged 18 to 70 years; 5. Sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Cervical and lumbar vertebral diseases (nerve root compression, spinal stenosis, cervical and lumbar degeneration), cerebral infarction, Guillain-Barre syndrome, severe arteriovenous vascular diseases (venous embolism, lymphangitis), drug neurotoxicity, metabolic toxic nerve injury; 2. Asymptomatic DSPN (only abnormal nerve conduction function); 3. Patients with diabetic foot in the middle and late stages; 4. Patients with severe cardiovascular, cerebrovascular, liver, kidney and hematopoietic diseases and psychosis; 5. Pregnant and lactating women; 6. Participants in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nerve Conduction Velocity (NCV); | — |
Secondary
| Measure | Time frame |
|---|---|
| the Michigan Diabetic Neuropathy Score (MDNS);the SF-36; | — |
Countries
China
Contacts
Public ContactJianwei Zhou
Institute of Traditional Chinese Medicine, Sichuan Academy of Traditional Chinese Medicine
Outcome results
None listed